Brief: Werewolf Therapeutics Reports First Quarter 2022 Financial Results And Provides Business Highlights

Werewolf Therapeutics

10/05/2022 12:35

May 10 (Reuters) - Werewolf Therapeutics Inc  HOWL.O :
    * WEREWOLF THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS HIGHLIGHTS
    * QTRLY  NET LOSS PER SHARE $0.56
    * AS OF MARCH 31, 2022, CASH AND CASH EQUIVALENTS WERE
$143.7
MILLION
    * Q1 EARNINGS PER SHARE VIEW $-0.62 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX7Y78s3 
Further company coverage:  HOWL.O 

 ((Reuters.Briefs@thomsonreuters.com;))